OHSU in the news

OHSU to pay $1 million, promises change to settle lawsuit from widow of cancer patient

The Oregonian May 04, 2022
OHSU will pay a $1 million settlement in response to a lawsuit regarding the death of a patient with cancer. OHSU statement: "OHSU extends its sincere condolences to the family and friends of Mr. McIntyre. As a community of healers devoted to advancing health, the passing of a patient, under any circumstances, is devastating to all involved. Patient privacy laws prevent us from disclosing protected health information; however, we want to share the following: • OHSU has followed, and continues to follow, national cancer guidelines and evidence-based medicine set forth by national expert consensus in the field. • National treatment guidelines established by the major cancer societies in the U.S. do not recommend DPD, or dihydropyrimidine dehydrogenase, testing prior to starting chemotherapy. • Although DPD testing is not part of the standard of care for delivering chemotherapy, OHSU is enhancing its educational component on DPD deficiency in its Oncology Fellowship program. • OHSU also plans to create a Resource Guide that describes DPD deficiency, how it relates to metabolism of capecitabine and what to look for in relationship to early-onset symptoms -- this Resource Guide will be available to everyone in the oncology department."

Oregon hospitals backlogged with non-COVID patients, impacting care

KGW-TV May 04, 2022
Renee Edwards, M.D., discusses ongoing high hospital capacity, urges the public to seek lower levels of care consistently, before medical needs become critical: "We'd rather you get the preventive care you need and the ongoing care you need to keep things from getting worse."

Normal families struggle with abnormal lives

Oregon Capital Chronicle May 03, 2022
The Oregon Capital Chronicle highlights the human impact of illicit fentanyl surging into Oregon. Rob Hendrickson, M.D., says of withdrawal symptoms: “It’s incredibly uncomfortable. You get diarrhea and vomiting, agitation and incredible cravings to take more.”
See more stories